These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1022953)

  • 1. A trial of long-acting sulphonamide R.O. 4-4393 (fanasil) in treatment of cases of lepromatous leprosy with repeated E.N.L.
    Ekambaram V; Venkatachari S
    Lepr India; 1976 Jan; 48(1):24-30. PubMed ID: 1022953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blind trial of weekly doses of sulforthomidine (fanasil (Roche)) and Disulone in lepromatous leprosy. Comparison of results after thirty months of treatment.
    Languillon J
    Int J Lepr Other Mycobact Dis; 1971; 39(2):471-5. PubMed ID: 4948086
    [No Abstract]   [Full Text] [Related]  

  • 3. Pattern of reactions in leprosy: a clinical appraisal.
    Sehgal VN; Rege VL; Mascarenhas MF
    Lepr India; 1977 Apr; 49(2):221-8. PubMed ID: 198609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical trial of sulforthomidine ('Fanasil' Roche) in lepromatous leprosy.
    Currie G
    Lepr Rev; 1966 Oct; 37(4):205-8. PubMed ID: 5341699
    [No Abstract]   [Full Text] [Related]  

  • 5. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trial of DADDS in lepromatous leprosy.
    Ganapati R; Naik SS; Shah MH; Shirsat LS; Gaitonde BB
    Lepr India; 1976 Jul; 48(3):238-43. PubMed ID: 799207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introductory rifampicin therapy in lepromatous leprosy: a six month follow-up study.
    Girdhar BK; Ramu G; Sreevatsa ; Desikan KV
    Lepr India; 1978 Jul; 50(3):363-70. PubMed ID: 359925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythema nodosum leprosum in Nigeria.
    Somorin AO
    Int J Dermatol; 1975 Nov; 14(9):664-6. PubMed ID: 1184260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
    Karat AB; Jeevaratnam A; Karat S; Rao PS
    Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
    [No Abstract]   [Full Text] [Related]  

  • 11. Lucio's phenomenon and diffuse nonnodular lepromatous leprosy.
    Rea TH; Levan NE
    Arch Dermatol; 1978 Jul; 114(7):1023-8. PubMed ID: 686719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of leprosy. I. Sulfones and sulfonamides].
    Leiker DL
    Ned Tijdschr Geneeskd; 1979 Jun; 123(23):969-72. PubMed ID: 460449
    [No Abstract]   [Full Text] [Related]  

  • 13. Leprosy XII. Quantitative analysis of thymus-derived lymphocyte response to phytohemagglutinin in leprosy.
    Lim SD; Jacobson RR; Park BH; Good RA
    Int J Lepr Other Mycobact Dis; 1975; 43(2):95-100. PubMed ID: 1081499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between regularity in dapsone (DDS) treatment and development of deformity.
    Radhakrishna S; Nair NG
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):425-34. PubMed ID: 3655458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative evaluation of levamisole in leprosy.
    Sharma L; Thalliath GH; Girgia HS; Sen PC
    Indian J Lepr; 1985; 57(1):11-6. PubMed ID: 3839808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nose in lepromatous leprosy; bacteriological and histopathological studies of patients treated with dapsone monotherapy for varying periods of time.
    Barton RP; Rees RJ; McDougall AC; Ellard GA
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):58-67. PubMed ID: 7200473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of leprosy and its complications.
    Trautman JR
    N Engl J Med; 1965 Sep; 273(14):756-8. PubMed ID: 5825688
    [No Abstract]   [Full Text] [Related]  

  • 20. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
    Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.